World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
19159
World Ranking
1775
National Ranking
876

Medicine

D-Index
78
Citations
19239
World Ranking
18157
National Ranking
9051

Ronald C. Montelaro publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ronald C. Montelaro sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 303 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ronald C. Montelaro D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ronald C. Montelaro sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ronald C. Montelaro is affiliated with the University of Pittsburgh in the United States. Their research primarily focuses on antimicrobial peptides and their applications, particularly in relation to antibiotic resistance and infectious diseases. Their work spans several intersecting fields, including immunology and microbiology as well as biochemistry, genetics, and molecular biology.

The scientist's recent publications illustrate a focus on the development and evaluation of engineered antimicrobial peptides to combat multidrug-resistant bacteria and improve therapeutic outcomes. Notable papers include Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria (2020, Science Advances), Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria (2020, Pharmaceutics), and Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class (2022, PLoS ONE). Other publications focus on pharmacological studies, such as the mass balance of antimicrobial peptides following intravenous administration (2020, Current Reviews in Clinical and Experimental Pharmacology), and immune signaling related to microbiota and autoimmune inflammation (2020, UNC Libraries).

Their scholarly work crosses multiple subfields, including microbiology, molecular medicine, organic chemistry, food science, and applied microbiology and biotechnology. These subfields contribute to and support their broader investigations in areas such as antimicrobial peptides and activities, antibiotic resistance in bacteria, antimicrobial agents and applications, probiotics and fermented foods, antibiotic use and resistance, pediatric health and respiratory diseases, and digestive system and related health.

  • Antimicrobial Peptides and Activities
  • Antibiotic Resistance in Bacteria
  • Antimicrobial agents and applications
  • Probiotics and Fermented Foods
  • Antibiotic Use and Resistance
  • Pediatric health and respiratory diseases
  • Digestive system and related health

Frequent co-authors collaborating with Montelaro include Berthony Deslouches, Y. Peter Di, Jonathan D. Steckbeck, Qiao Lin, and Chen Chen. These collaborations indicate a multidisciplinary approach to studying antimicrobial strategies and molecular therapeutics.

Ronald C. Montelaro's work has been published in several academic venues, including Science Advances, Pharmaceutics, PLoS ONE, Current Reviews in Clinical and Experimental Pharmacology, and UNC Libraries. Each of these platforms reflects a commitment to research at the intersection of microbiology, pharmacology, and clinical application.

  • Science Advances
  • Pharmaceutics
  • PLoS ONE
  • Current Reviews in Clinical and Experimental Pharmacology
  • UNC Libraries

Best Publications

  • Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys

    Michael Murphey-Corb;Louis N. Martin;S. R. S. Rangan;Gary B. Baskin

  • A formalin-inactivated whole SIV vaccine confers protection in macaques

    Michael Murphey-Corb;Louis N. Martin;Billie Davison-Fairburn;Ronald C. Montelaro

  • Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis

    Olivia Salinovich;Ronald C. Montelaro

  • A General Model for the Transmembrane Proteins of HIV and Other Retroviruses

    William R. Gallaher;Judith M. Ball;Robert F. Garry;Mark C. Griffin

  • Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.

    L J Parent;R P Bennett;R C Craven;T D Nelle

  • Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation

    Pawan Kumar;Leticia Monin;Patricia Castillo;Waleed Elsegeiny

  • De Novo Generation of Cationic Antimicrobial Peptides: Influence of Length and Tryptophan Substitution on Antimicrobial Activity

    Berthony Deslouches;Shruti M. Phadke;Vanja Lazarevic;Michael Cascio

  • Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.

    Bridget A. Puffer;Leslie J. Parent;John W. Wills;Ronald C. Montelaro

  • Assembly of type C oncornaviruses: a model.

    DP Bolognesi;RC Montelaro;H Frank;W Schafer

  • Equine Infectious Anemia Virus (EIAV): what has HIV’s country cousin got to tell us?

    Caroline Leroux;Jean-Luc Cadoré;Jean-Luc Cadoré;Ronald C Montelaro

  • Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.

    R C Montelaro;B Parekh;A Orrego;C J Issel

  • Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.

    R. Paul Johnson;Jeffrey D. Lifson;Susan C. Czajak;Kelly Stefano Cole

  • Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

    Kelly Stefano Cole;Jennifer L. Rowles;Beth A. Jagerski;Michael Murphey-Corb

  • The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles.

    David J. Schibli;Ronald C. Montelaro;Hans J. Vogel

  • Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.

    J E Clements;R C Montelaro;M C Zink;A M Amedee

  • Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.

    S A Hammond;S J Cook;D L Lichtenstein;C J Issel

  • Distinct subsets of retroviruses encode dUTPase.

    John H. Elder;Danica L. Lerner;Cynthia S. Hasselkus-Light;Darrell J. Fontenot

  • Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.

    O Salinovich;S L Payne;R C Montelaro;K A Hussain

  • Passive Immunization of Newborn Rhesus Macaques Prevents Oral Simian Immunodeficiency Virus Infection

    Koen K. A. Van Rompay;Christopher J. Berardi;Stephan Dillard-Telm;Ross P. Tarara

  • Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load.

    Collin R. Diedrich;Joshua T. Mattila;Edwin Klein;Chris Janssen

  • Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.

    J. D. Fontenot;N. Tjandra;D. Bu;Chien Ho

  • Activity of the De Novo Engineered Antimicrobial Peptide WLBU2 against Pseudomonas aeruginosa in Human Serum and Whole Blood: Implications for Systemic Applications

    Berthony Deslouches;Kazi Islam;Jodi K. Craigo;Shruti M. Paranjape

  • Rational Design of Engineered Cationic Antimicrobial Peptides Consisting Exclusively of Arginine and Tryptophan, and Their Activity against Multidrug-Resistant Pathogens

    Berthony Deslouches;Jonathan D. Steckbeck;Jodi K. Craigo;Yohei Doi

Frequent Co-Authors

Charles J. Issel
Charles J. Issel University of Kentucky
Michael Murphey-Corb
Michael Murphey-Corb University of Pittsburgh
Simon C. Watkins
Simon C. Watkins University of Pittsburgh
Yohei Doi
Yohei Doi University of Pittsburgh
Janice E. Clements
Janice E. Clements Johns Hopkins University School of Medicine
Phalguni Gupta
Phalguni Gupta University of Pittsburgh
Robert F. Garry
Robert F. Garry Tulane University
Olivera J. Finn
Olivera J. Finn University of Pittsburgh
Donna B. Stolz
Donna B. Stolz University of Pittsburgh
Stephanie Tristram-Nagle
Stephanie Tristram-Nagle Carnegie Mellon University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Nursing professionals, for example, can enhance their expertise through various specialized programs. Those looking for affordable options might consider the cheapest psych np programs online, which offer flexible learning while preparing students for advanced practice roles in mental health.

Transitioning within nursing specialties is also common. If you currently hold a Family Nurse Practitioner (FNP) certification and want to advance your skills, programs such as the fnp to acute care np bridge program provide practical routes to specialize in acute care settings.

Accelerated pathways can help motivated professionals achieve their goals faster. Many online options exist for students enrolled in accelerated fnp programs, designed to streamline study and certification for those with prior experience or degrees.

Finally, understanding the financial outlook is crucial when choosing a career. The dnp salary varies by location and specialty, influencing decisions about program investment and career planning in healthcare fields closely related to Immunology.

Best Scientists Citing Ronald C. Montelaro

Trending Scientists

Recently Published Articles